IVAX Corporation
IVAX Corporation
Aquisitions
In 2004, IVAX is reported to have aquired ChemSource Corporation (which is based in Puerto Rico)[1] .
ChemSource is reported to have 'recently entered into a license agreement with Novartis Pharma AG to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'[2].
In July 2003, Business Wire reports that IVAX 'received the first of a series of payments from B Braun Melsungen AG, under a number of agreements, for certain patent and product rights and for settlement of litigation'[3].
Brands, Divisions and Affiliates
In 2004, Plunkett's Health Care Industry Almanac reports the following 'Brands/Divisions/Affiliates' of IVAX[4]...
- Airmax
- Easi-Breathe
- Paxene
- Paxoral
- TP-38
- ChemSource Corporation
- IVAX Pharmaceuticals Inc.
- Novartis Pharma AG
References
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
- ↑ Business Wire 'IVAX Reports Increased Revenues and Net Income for 2nd Quarter of 2003; 2Q2003 Net Revenues Up 22% to $343 Million, Net Income Up 30% to $41.3 Million' 30th July 2003. Miami
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
